FDA Investigator Devaugh Edwards
Devaugh Edwards has inspections in 3 countries as of 11 Nov 2022. Devaugh Edwards has collaborated with a combined 1087 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
4
Last Inspection Date:
11 Nov 2022
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
France,
India,
United States of America
Co-Investigator(s):
Aaron P Wozniak,
Adam R Cooke,
Amy H Ruble,
Angela E Glenn,
Babatunde D Babalola,
Barbara I Rogolsky,
Barbara L Rogolsky,
Barbara M Frazier,
Bonita S Chester,
CDR Thomas R Berry, PPh,
Charisse K Green,
Cheryl A Clausen,
Claudette D Brooks,
Daniel J Roberts,
Daphne Santiago, PhD,
Denise M Digiulio,
Devaughn Edwards,
Gideon N Esuzor,
Helen Verdel,
Jason F Chancey,
Jawaid Hamid,
Jogy George,
Joseph F Owens,
Julianne C Mccullough,
Kathleen D Culver,
Katrina B Mosley Sloan,
Kenneth H Williams,
Larry K Austin,
Larry K Hampton,
Laurie Nelson,
Lesley K Satterwhite,
LT Tamara J Henderson,
Luis A Dasta,
Marie F Morin,
Marisa E Stock,
Matthew M Henciak,
Megan A Haggerty,
Melanie M Walker,
Melissa J Garcia,
Michael A Charles,
Paul A Bonneau,
Penny H Mccarver,
Rachael L Cook,
Robert C Coleman,
Robert L Lewis, Jr,
Rozelle G Smith,
Saleem A Akhtar,
Santos E Camara,
Sayeeda Hdabe,
Seneca D Toms,
Sonya M Edmonds,
Steven Fong, MS, PhD,
Tamara M Felton,
Tammara A Stephens,
Thomas J Arista,
Vani Mathur Richards,
Viviana Matta,
Vlada Matusovsky,
Walden H Lee,
Xiomara Copeland,
Zhao Wang, PhD
Devaugh Edwards's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2000 | FDA 483 Response | CIPLA LIMITED - Form 483R, 2000-09-07 |
September, 2003 | EIR | Hospira, Inc. - EIR, 2003-09-04 |
August, 2000 | EIR | CIPLA LIMITED - EIR, 2000-08-24 |
November, 2005 | EIR | PCAS - EIR, 2005-11-22 |
July, 2003 | EIR | Alcami Carolinas Corporation - EIR, 2003-07-10 |
November, 2005 | FDA 483 Response | PCAS - Form 483R, 2005-11-22 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more